Healthcare of Ontario Pension Plan Trust Fund Lowers Position in Synopsys, Inc. $SNPS

Posted by Brian Himes on Jul 27th, 2026

Healthcare of Ontario Pension Plan Trust Fund trimmed its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 3.1% during the 1st quarter, Holdings Channel reports. The fund owned 62,255 shares of the semiconductor company’s stock after selling 1,972 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Synopsys were worth $24,683,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of Synopsys by 1.6% in the 4th quarter. Vanguard Group Inc. now owns 18,464,862 shares of the semiconductor company’s stock worth $8,673,315,000 after purchasing an additional 283,677 shares during the period. State Street Corp raised its stake in Synopsys by 0.3% in the fourth quarter. State Street Corp now owns 8,788,890 shares of the semiconductor company’s stock worth $4,128,317,000 after buying an additional 28,532 shares in the last quarter. Morgan Stanley raised its stake in Synopsys by 2.5% in the fourth quarter. Morgan Stanley now owns 4,573,980 shares of the semiconductor company’s stock worth $2,148,491,000 after buying an additional 109,917 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Synopsys by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 4,310,846 shares of the semiconductor company’s stock worth $2,017,256,000 after buying an additional 54,329 shares during the period. Finally, Van ECK Associates Corp lifted its holdings in Synopsys by 17.0% during the fourth quarter. Van ECK Associates Corp now owns 2,593,619 shares of the semiconductor company’s stock worth $1,218,275,000 after buying an additional 376,711 shares during the period. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on SNPS. Zacks Research upgraded Synopsys from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 30th. Robert W. Baird set a $558.00 price objective on Synopsys in a research report on Thursday, May 28th. Stifel Nicolaus lifted their target price on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Bank of America boosted their target price on shares of Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Finally, BNP Paribas Exane increased their price target on shares of Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a research report on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $570.06.

Read Our Latest Stock Report on SNPS

Synopsys Price Performance

Synopsys stock opened at $373.47 on Monday. Synopsys, Inc. has a 1-year low of $366.00 and a 1-year high of $651.73. The business has a fifty day moving average price of $456.13 and a 200-day moving average price of $454.98. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The stock has a market capitalization of $71.51 billion, a price-to-earnings ratio of 86.45, a PEG ratio of 2.19 and a beta of 1.22.

Synopsys (NASDAQ:SNPS – Get Free Report) last announced its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.15 by $0.20. The company had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm’s quarterly revenue was up 41.9% compared to the same quarter last year. During the same period in the prior year, the company posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts forecast that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.

Insider Activity at Synopsys

In other Synopsys news, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.56% of the company’s stock.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.